JP5658696B2 - 皮膚のストレス蓄積度の評価方法 - Google Patents
皮膚のストレス蓄積度の評価方法 Download PDFInfo
- Publication number
- JP5658696B2 JP5658696B2 JP2012012033A JP2012012033A JP5658696B2 JP 5658696 B2 JP5658696 B2 JP 5658696B2 JP 2012012033 A JP2012012033 A JP 2012012033A JP 2012012033 A JP2012012033 A JP 2012012033A JP 5658696 B2 JP5658696 B2 JP 5658696B2
- Authority
- JP
- Japan
- Prior art keywords
- skin
- hsp27
- stratum corneum
- expression level
- stress
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000009825 accumulation Methods 0.000 title claims description 40
- 238000011156 evaluation Methods 0.000 title claims description 25
- 210000003491 skin Anatomy 0.000 claims description 110
- 108010045100 HSP27 Heat-Shock Proteins Proteins 0.000 claims description 102
- 210000000434 stratum corneum Anatomy 0.000 claims description 86
- 230000014509 gene expression Effects 0.000 claims description 53
- 238000000034 method Methods 0.000 claims description 40
- 230000037307 sensitive skin Effects 0.000 claims description 26
- 238000005259 measurement Methods 0.000 claims description 13
- 238000005070 sampling Methods 0.000 claims description 10
- 102000002812 Heat-Shock Proteins Human genes 0.000 claims description 7
- 108010004889 Heat-Shock Proteins Proteins 0.000 claims description 7
- 230000000638 stimulation Effects 0.000 claims description 5
- 102100039165 Heat shock protein beta-1 Human genes 0.000 claims 2
- 102000005623 HSP27 Heat-Shock Proteins Human genes 0.000 description 100
- 230000035882 stress Effects 0.000 description 57
- 108090000623 proteins and genes Proteins 0.000 description 41
- 102000004169 proteins and genes Human genes 0.000 description 41
- 238000002474 experimental method Methods 0.000 description 22
- 239000002537 cosmetic Substances 0.000 description 18
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 15
- 239000000284 extract Substances 0.000 description 15
- 230000036074 healthy skin Effects 0.000 description 15
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 15
- 229940083575 sodium dodecyl sulfate Drugs 0.000 description 14
- 238000011002 quantification Methods 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 238000000265 homogenisation Methods 0.000 description 9
- 206010012438 Dermatitis atopic Diseases 0.000 description 8
- 201000008937 atopic dermatitis Diseases 0.000 description 8
- 230000005068 transpiration Effects 0.000 description 8
- 230000035945 sensitivity Effects 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 230000000903 blocking effect Effects 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- 238000000751 protein extraction Methods 0.000 description 6
- 206010015150 Erythema Diseases 0.000 description 5
- 235000010724 Wisteria floribunda Nutrition 0.000 description 5
- 210000000245 forearm Anatomy 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 238000000605 extraction Methods 0.000 description 4
- 230000037311 normal skin Effects 0.000 description 4
- 238000002731 protein assay Methods 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 238000001262 western blot Methods 0.000 description 4
- 241000283707 Capra Species 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 3
- 239000002033 PVDF binder Substances 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 206010040880 Skin irritation Diseases 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000011544 gradient gel Substances 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 230000007803 itching Effects 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 3
- BBKDWPHJZANJGB-IKJXHCRLSA-N quizalofop-P-tefuryl Chemical compound O=C([C@H](OC=1C=CC(OC=2N=C3C=CC(Cl)=CC3=NC=2)=CC=1)C)OCC1CCCO1 BBKDWPHJZANJGB-IKJXHCRLSA-N 0.000 description 3
- 231100000475 skin irritation Toxicity 0.000 description 3
- 230000036556 skin irritation Effects 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 206010003645 Atopy Diseases 0.000 description 2
- 101100339887 Drosophila melanogaster Hsp27 gene Proteins 0.000 description 2
- 238000008157 ELISA kit Methods 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 101150096895 HSPB1 gene Proteins 0.000 description 2
- 101001036709 Homo sapiens Heat shock protein beta-1 Proteins 0.000 description 2
- 102000011782 Keratins Human genes 0.000 description 2
- 108010076876 Keratins Proteins 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 210000001217 buttock Anatomy 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 102000053548 human HSPB1 Human genes 0.000 description 2
- 238000004020 luminiscence type Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 206010040882 skin lesion Diseases 0.000 description 2
- 231100000444 skin lesion Toxicity 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 238000000035 BCA protein assay Methods 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 230000007035 DNA breakage Effects 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 108010006519 Molecular Chaperones Proteins 0.000 description 1
- 102000005431 Molecular Chaperones Human genes 0.000 description 1
- 239000012083 RIPA buffer Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000002306 biochemical method Methods 0.000 description 1
- 238000010876 biochemical test Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000009223 counseling Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000006355 external stress Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000010413 gardening Methods 0.000 description 1
- 230000008799 immune stress Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 229910052724 xenon Inorganic materials 0.000 description 1
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
- A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
- A61B5/443—Evaluating skin constituents, e.g. elastin, melanin, water
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/20—Dermatological disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/40—Disorders due to exposure to physical agents, e.g. heat disorders, motion sickness, radiation injuries, altitude sickness, decompression illness
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Surgery (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012012033A JP5658696B2 (ja) | 2011-02-25 | 2012-01-24 | 皮膚のストレス蓄積度の評価方法 |
KR1020137014928A KR20130140069A (ko) | 2011-02-25 | 2012-02-14 | 피부의 스트레스 축적도의 평가방법 |
CN2012800090971A CN103380375A (zh) | 2011-02-25 | 2012-02-14 | 皮肤的应激积累度的评价方法 |
PCT/JP2012/053345 WO2012114932A1 (ja) | 2011-02-25 | 2012-02-14 | 皮膚のストレス蓄積度の評価方法 |
TW101105615A TWI580964B (zh) | 2011-02-25 | 2012-02-21 | 皮膚的壓力蓄積度的評價方法 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011040355 | 2011-02-25 | ||
JP2011040355 | 2011-02-25 | ||
JP2012012033A JP5658696B2 (ja) | 2011-02-25 | 2012-01-24 | 皮膚のストレス蓄積度の評価方法 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2012189581A JP2012189581A (ja) | 2012-10-04 |
JP2012189581A5 JP2012189581A5 (zh) | 2014-09-11 |
JP5658696B2 true JP5658696B2 (ja) | 2015-01-28 |
Family
ID=46720714
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012012033A Active JP5658696B2 (ja) | 2011-02-25 | 2012-01-24 | 皮膚のストレス蓄積度の評価方法 |
Country Status (5)
Country | Link |
---|---|
JP (1) | JP5658696B2 (zh) |
KR (1) | KR20130140069A (zh) |
CN (1) | CN103380375A (zh) |
TW (1) | TWI580964B (zh) |
WO (1) | WO2012114932A1 (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5731598B2 (ja) * | 2012-11-02 | 2015-06-10 | 株式会社ファンケル | 荒れ肌の評価方法 |
CN103808940B (zh) * | 2012-11-02 | 2017-06-06 | 株式会社芳珂 | 粗糙肌肤的评价方法 |
JP5775540B2 (ja) * | 2013-02-22 | 2015-09-09 | 株式会社ファンケル | 皮膚の紫外線照射により負荷される紫外線ストレスの評価方法 |
JP2015072226A (ja) * | 2013-10-03 | 2015-04-16 | 住友ベークライト株式会社 | 検査方法 |
JP5977268B2 (ja) * | 2014-01-09 | 2016-08-24 | 株式会社ファンケル | 肌理の評価方法 |
JP6530646B2 (ja) * | 2015-06-22 | 2019-06-12 | 株式会社ファンケル | 頭皮の圧縮応力の評価方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1703229B (zh) * | 2002-10-02 | 2011-01-05 | 英属哥伦比亚大学 | 治疗前列腺和其他癌的组合物和其制备药物的用途 |
JP4469762B2 (ja) * | 2005-07-26 | 2010-05-26 | 株式会社資生堂 | 敏感肌の評価方法及びその評価キット |
JP5362219B2 (ja) * | 2005-08-23 | 2013-12-11 | 株式会社ファンケル | 皮膚老化マーカーとその利用技術 |
JP4954908B2 (ja) * | 2008-01-21 | 2012-06-20 | 株式会社 資生堂 | 角層タンパク質の可溶性タンパク質の量比を指標とした肌質の評価方法 |
-
2012
- 2012-01-24 JP JP2012012033A patent/JP5658696B2/ja active Active
- 2012-02-14 WO PCT/JP2012/053345 patent/WO2012114932A1/ja active Application Filing
- 2012-02-14 KR KR1020137014928A patent/KR20130140069A/ko not_active Application Discontinuation
- 2012-02-14 CN CN2012800090971A patent/CN103380375A/zh active Pending
- 2012-02-21 TW TW101105615A patent/TWI580964B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN103380375A (zh) | 2013-10-30 |
TW201235662A (en) | 2012-09-01 |
KR20130140069A (ko) | 2013-12-23 |
TWI580964B (zh) | 2017-05-01 |
JP2012189581A (ja) | 2012-10-04 |
WO2012114932A1 (ja) | 2012-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5658696B2 (ja) | 皮膚のストレス蓄積度の評価方法 | |
Brach et al. | The reliability and validity of measures of gait variability in community-dwelling older adults | |
Hadi et al. | The investigation of the skin biophysical measurements focusing on daily activities, skin care habits, and gender differences | |
Anthonissen et al. | Reliability of Repeated Measurements on Post‐Burn Scars with Corneometer CM 825® | |
Murdan et al. | An assessment of the human nail plate pH | |
Lee et al. | Different cosmetic habits can affect the biophysical profile of facial skin: a study of korean and chinese women | |
JP5065237B2 (ja) | アトピー性皮膚炎の局所病態の非侵襲的評価方法 | |
Zeytun | Demodex (Acari: Demodicidae) infestation in the elderly and its relationship with the skin parameters such as moisture, pH, and temperature: a cross-sectional study. | |
JP5775540B2 (ja) | 皮膚の紫外線照射により負荷される紫外線ストレスの評価方法 | |
JP4469762B2 (ja) | 敏感肌の評価方法及びその評価キット | |
JP5775538B2 (ja) | 紫外線曝露によって誘発される赤み(発赤)発生及び白さの低下に対する抵抗性の評価方法 | |
Padmanabhan et al. | Which is more prevalent among the female population-Osteopenia or Osteoporosis? A cross sectional study | |
López-Jornet et al. | Study of lip hydration with application of photoprotective lipstick: influence of skin phototype, size of lips, age, sex and smoking habits | |
Huygen et al. | Skin Barrier Function Assessment: Electrical Impedance Spectroscopy Is Less Influenced by Daily Routine Activities Than Transepidermal Water Loss | |
Koh et al. | The relationship between periwound skin condition and venous leg ulcer chronicity | |
JP5700705B2 (ja) | 皮膚の乾燥ストレス量の測定方法 | |
KR101515189B1 (ko) | 인체 피부의 일차자극 평가 기준에 따른 화장품 안전성 평가 방법 | |
Farage | Sensory, Clinical, and Physiological Factors in Sensitive Skin | |
Farage et al. | Sensitive skin: intrinsic and extrinsic contributors | |
Dykes | THE MOISTURISING PROPERTIES OF A HEEL BALM IN PATIENTS WITH ROUGH DRY SKIN. | |
Paul et al. | Detection of skin alterations in mild-to-moderate chronic venous disease using non-invasive techniques | |
Farage | Understanding the Sensitive Skin Subject to Achieve a More Holistic Diagnosis. Cosmetics 2021, 8, 81 | |
Diehl | The burden of sensitive skin | |
Mawardi et al. | Profile of Skin Disease in Elderly at Panti Wredha Surakarta | |
Putra et al. | Quality of Life Assessment in Skin Tag Patients |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140728 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20140728 |
|
A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20140728 |
|
A975 | Report on accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A971005 Effective date: 20140814 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140826 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20141021 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20141125 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20141128 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5658696 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |